Glenmark Pharma secures place in Dow Jones Sustainability Rising Markets Index
The drug maker has been listed within the Dow Jones Sustainability Index (DJSI), beneath the class of rising markets for the third consecutive yr in a row.
DJSI is without doubt one of the world’s premier benchmarks for sustainable enterprise practices. Glenmark is ranked 13th amongst international pharmaceutical firms. It’s amongst solely 11 firms from India and one of many two firms from the pharmaceutical sector to be listed within the DJSI Rising Markets Index this yr.
The DJSI analyses firms on their company financial, environmental and social efficiency, to evaluate points equivalent to however not restricted to company governance, danger administration, environmental coverage & administration programs, provide chain administration, occupational well being and security, labor practices, innovation and cyber safety amongst others.
Inclusion on this checklist is taken into account extremely prestigious by international traders, monetary analysts and different stakeholders and serves as a benchmark for traders who combine sustainability issues into their portfolios.
Shares of Glenmark Prescription drugs rose 0.40% to Rs 468.25.
The drug maker’s consolidated internet revenue slipped 8.4% to Rs 233.99 crore on 5.2% improve in internet gross sales to Rs 2,908.12 crore in Q2 September 2020 over Q2 September 2019.
Glenmark Prescription drugs is a world research-led pharmaceutical firm with presence throughout generics, specialty and over-the-counter (OTC) enterprise with operations in over 50 nations. Glenmark’s key remedy focus areas globally are respiratory, dermatology and oncology.
Powered by Capital Market – Reside Information
(This story has not been edited by Enterprise Commonplace employees and is auto-generated from a syndicated feed.)
Market information on CNN.